For generations, depression has been treated as though it speaks with one voice — but a team of Australian researchers has found that for roughly one in four patients, the disorder originates not in disrupted neurochemistry or unresolved trauma, but in a body clock so far adrift from the rhythms of the world that the person lives in a kind of permanent temporal exile. Published in the British Journal of Psychiatry and drawn from over eleven thousand participants, the findings suggest that matching treatment to the underlying mechanism — rather than the surface symptom — may be the key to reach
Researchers Identify 'Circadian' Depression Subtype Affecting 1 in 4 Patients
Patients with circadian depression experience earlier symptom onset, more severe clinical features including suicidality and psychosis, and greater treatment resistance.
They live in perpetual jet lag, and we've been treating them wrong
Mark
So one in four people with depression have this circadian version. That's a huge proportion. How confident are the researchers that this is actually a distinct subtype and not just another way of describing depression that already has a name?
Mimi
There's some overlap with atypical depression, which is real. But even when you account for that, about 1,400 people in the study fit the circadian criteria but not atypical depression. The six markers they identified—seasonal changes, delayed sleep midpoint, social jet lag, evening chronotype, sleeping longer when possible, morning fatigue—they cluster together in a way that suggests something coherent is happening.
Luke
But I want to be careful here. The study is observational. They found these six traits correlate in 25 percent of their sample. That's not the same as proving these people have a distinct biological disorder. It's a pattern worth investigating, but the causal mechanism—the actual broken clock in the brain—that's still being worked out.
Mark
Fair point. But if these patients aren't responding to standard antidepressants, doesn't that suggest something different is going on?
Mimi
Yes. And that's the practical payoff. Whether or not we fully understand the mechanism, if light therapy and melatonin work better for these patients than SSRIs, then identifying them early matters enormously.
Luke
Agreed. Though I'd note the study doesn't actually test whether light therapy works better. It identifies the subtype and shows these patients respond poorly to antidepressants. The next step—actually comparing circadian-targeted treatments to standard ones in this population—that hasn't happened yet.
Mark
So this is the diagnosis, not the cure.
Mimi
Exactly. It's saying: here's a group we've been treating wrong. Here's why. Now let's test what actually helps them.
Luke
And that's important because these patients are experiencing more severe symptoms—more suicidality, more psychosis—so getting the treatment right could genuinely save lives.
Mark
How many people are we talking about globally?
Mimi
The study looked at 11,380 Australians, so we don't know if the one-in-four figure holds everywhere. But if it does, that's tens of millions of people worldwide.
Luke
Which is why the next phase of research—actually testing whether circadian interventions work—is so urgent.
Le Pouls
- One in four depression patients may have been misdiagnosed in practice — not in label, but in treatment — because their illness is driven by a misaligned circadian clock, not the anxiety-based chemistry that most antidepressants are designed to address.
- These patients carry a heavier burden: earlier onset, more frequent mania and suicidal ideation, greater weight gain, and a genetic profile that also elevates risk for ADHD and cardiovascular disease.
- The experience is described as living in perpetual jet lag — exhaustion that never lifts, sleep that arrives too late, mornings that feel like emergencies — a mismatch between the body's internal time and the world's external schedule.
- Standard antidepressants not only tend to fail this group but may actively cause harm through side effects, leaving patients in a cycle of treatment resistance that has long lacked a biological explanation.
- Researchers are now pointing toward light therapy and melatonin as more targeted interventions, urging clinicians to screen for circadian markers early rather than defaulting to medications that were never built for this form of the disorder.
For generations, depression has been treated as though it speaks with one voice — but a team of Australian researchers has found that for roughly one in four patients, the disorder originates not in disrupted neurochemistry or unresolved trauma, but in a body clock so far adrift from the rhythms of the world that the person lives in a kind of permanent temporal exile. Published in the British Journal of Psychiatry and drawn from over eleven thousand participants, the findings suggest that matching treatment to the underlying mechanism — rather than the surface symptom — may be the key to reaching those whom medicine has repeatedly failed.
Depression looks the same from the outside — the sleeplessness, the heaviness, the withdrawal — but the machinery underneath is not always identical. A research team led by Jacob Crouse and Ian Hickie at the University of Sydney has identified a distinct circadian subtype of the disorder, one driven not by disrupted neurotransmitters but by a fundamental desynchronization between the body's internal clock and the external world. Their analysis of 11,380 participants in the Australian Genetics of Depression Study, published in the British Journal of Psychiatry, found that roughly one in four patients fit this profile.
The circadian system governs sleep, mood, metabolism, and concentration through a 24-hour rhythm calibrated primarily by light. When it falls out of alignment, Hickie explains, the result resembles permanent jet lag: exhaustion that doesn't lift, weight gain, fractured sleep, and an inability to focus. The researchers identified six markers — symptoms that worsen seasonally, delayed sleep timing, pronounced social jet lag between workdays and weekends, an evening chronotype, longer sleep duration when unrestricted, and severe morning fatigue.
The approximately 1,400 participants who met these criteria showed a more severe clinical picture than other depression patients: earlier onset, higher rates of mania, psychosis, and suicidal ideation, greater weight gain during episodes, and elevated genetic risk for both ADHD and cardiovascular disease. Most critically, they were less likely to respond to standard antidepressants and more likely to experience adverse effects from them.
First author Emiliana Tonini noted that recognizing distinct subtypes matters precisely because it allows clinicians to stop cycling patients through treatments that were never designed for their condition. For circadian depression, the more logical interventions are those that reset the clock itself — light therapy, melatonin, and other circadian-targeting approaches. Crouse urged that these be considered earlier in patients showing circadian markers, rather than as a last resort. For the many people whose depression has resisted every standard treatment, the research offers something rare: not just an explanation, but a different direction entirely.
Depression looks the same from the outside. A person stops sleeping well. They lose interest in things. They feel heavy, stuck, unreachable. But the machinery underneath that heaviness is not always the same. Some people's depression runs on broken chemistry. Some runs on trauma. Some, researchers now believe, runs on a body clock that has drifted so far from the world around it that the person lives in a state of permanent jet lag.
A team led by psychiatry researchers Jacob Crouse and Ian Hickie at the University of Sydney set out to test whether this circadian misalignment might explain why so many people with depression don't respond to the medications doctors reach for first. They analyzed data from 11,380 participants in the ongoing Australian Genetics of Depression Study and published their findings in the British Journal of Psychiatry. What they found was striking: roughly one in four of those patients fit a distinct circadian subtype of depression, driven not by the anxiety-based mechanisms that most antidepressants target, but by a fundamental desynchronization between the body's internal rhythms and the external world.
The circadian system is the body's 24-hour clock, calibrated mainly by light exposure. It governs sleep, mood, metabolism, concentration, and dozens of other functions that most people never think about because they work quietly in the background. When that system falls out of sync, Hickie explains, the result feels like living in a perpetual state of jet lag: exhaustion that doesn't lift, weight gain, poor sleep, inability to focus, behavioral changes. The researchers identified six markers of circadian depression. Symptoms worsen with seasonal changes as day length shifts. Sleep arrives later than typical. People experience "social jet lag," where their sleep timing on workdays differs by several hours from weekends, creating a constant mismatch between their body's needs and society's schedule. They have an evening chronotype—they are naturally wired to stay up late and sleep in. When given the chance, they sleep longer than average, perhaps because their bodies are trying to recover from the constant experience of misalignment. And they report severe morning fatigue.
Among the 11,380 study participants, about 1,400 people met criteria for the circadian subtype. These patients tended to develop depression earlier in life than others. Their symptoms were more severe, including higher rates of mania, psychosis, and suicidal thoughts. They gained more weight during depressive episodes. They carried higher genetic risk for ADHD and for inflammatory and cardiovascular disease. And crucially, they were less likely to respond to standard antidepressants and more likely to experience side effects from them.
There was some overlap with other proposed depression subtypes—particularly with atypical depression, which also doesn't respond well to conventional treatments. But even accounting for that overlap, the circadian subtype appeared to be a distinct form of the disorder. Emiliana Tonini, the study's first author, noted that recognizing these different subtypes matters because it could allow clinicians to match patients with treatments that actually work for them, rather than cycling through medications that don't.
For circadian depression, the implications are straightforward. If the problem is a misaligned internal clock, then treatments that reset that clock—light therapy, melatonin, potentially other circadian-targeting interventions—should be more effective than medications designed to rebalance neurotransmitters. Crouse emphasized that clinicians should consider these approaches earlier in patients who show circadian depression markers, rather than defaulting to antidepressants that may not help and could cause harm. For the millions of people whose depression has resisted standard treatment, the finding offers something rare: a biological explanation for why they haven't gotten better, and a different path forward.
Citations marquantes
When the circadian system is off, you feel jet-lagged all the time. You feel tired, exhausted, gain weight, can't concentrate, sleep poorly, and your behavior changes.— Ian Hickie, psychiatry researcher, University of Sydney
Depression is not a uniform illness. Understanding different subtypes means we can give people earlier access to treatments that will be most effective for them.— Emiliana Tonini, first author of the study
Envie de l'histoire complète ?
Lire l'original sur ScienceAlert ↗
Health & Medicine